A Swedish startup aims to dominate stem cell production while nanotechnology is helping to transform cancer care. What does it mean for investors?
SINGAPORE, SINGAPORE, August 8, 2025 /EINPresswire.com/ -- CytoNiche Biotech, a leader in 3D cell production technology, has opened its 3D FloTrix™ Experience Hub ...
Hosted on MSN
Sana Biotechnology showcases successful in vivo gene editing of stem cells in Nature publication
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to invest in. On December 8, Sana Biotechnology announced the publication of groundbreaking preclinical data in the ...
K orea-based biotechnology company Nature Cell plans to open a manufacturing facility in Baltimore City, Maryland. The approximately 100,000-square-foot operation at the Gaslight Square mixed-use ...
Korean biotechnology company, Nature Cell, is planning to open a stem cell facility in Baltimore, bringing 500 new jobs, the governor announced Tuesday. The 100,000 square foot manufacturing facility ...
Baltimore is adding a new life sciences heavyweight to its roster. Maryland has a strong life sciences workforce, which employs over 54,000 people. Nature Cell, a Korean biotech firm, plans to open a ...
Biotech firm Gameto has raised $44 million from investors to bring a late-stage clinical trial on its fertility treatment over the finish line, the company, which has a lab in Kips Bay and recently ...
SINGAPORE, April 24, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based property management services provider and a leading non-invasive ...
Fortress Biotech, Inc. and its subsidiary Helocyte, Inc. have initiated a Phase 2 clinical trial to assess the efficacy of the Triplex vaccine, designed to prevent cytomegalovirus (CMV) reactivation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results